A new trading day began on Tuesday, with Zimmer Biomet Holdings Inc (NYSE: ZBH) stock price down -1.56% from the previous day of trading, before settling in for the closing price of $124.00. ZBH’s price has ranged from $102.00 to $149.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -1.20%. Meanwhile, its annual earnings per share averaged 6.81%. With a float of $204.81 million, this company’s outstanding shares have now reached $205.60 million.
Considering the fact that the conglomerate employs 18000 people, you should pay attention to its efficiency factor.
Zimmer Biomet Holdings Inc (ZBH) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Zimmer Biomet Holdings Inc is 0.13%, while institutional ownership is 91.02%. The most recent insider transaction that took place on Mar 07 ’24, was worth 216,296. In this transaction Group President, Asia Pacific of this company sold 1,705 shares at a rate of $126.86, taking the stock ownership to the 18,179 shares. Before that another transaction happened on Feb 22 ’24, when Company’s Sr. VP/Gen Counsel/Secretary sold 26,156 for $128.62, making the entire transaction worth $3,364,126. This insider now owns 44,145 shares in total.
Zimmer Biomet Holdings Inc (ZBH) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 26.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.81% per share during the next fiscal year.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Trading Performance Indicators
Here are Zimmer Biomet Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.39. Likewise, its price to free cash flow for the trailing twelve months is 25.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.89, a number that is poised to hit 1.87 in the next quarter and is forecasted to reach 8.69 in one year’s time.
Technical Analysis of Zimmer Biomet Holdings Inc (ZBH)
Compared to the last year’s volume of 1.48 million, its volume of 1.13 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 7.32%. Additionally, its Average True Range was 2.41.
During the past 100 days, Zimmer Biomet Holdings Inc’s (ZBH) raw stochastic average was set at 45.08%, which indicates a significant increase from 5.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.29% in the past 14 days, which was higher than the 17.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $126.52, while its 200-day Moving Average is $121.60. Nevertheless, the first resistance level for the watch stands at $123.79 in the near term. At $125.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $126.71. If the price goes on to break the first support level at $120.87, it is likely to go to the next support level at $119.68. Now, if the price goes above the second support level, the third support stands at $117.95.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Key Stats
With a market capitalization of 25.03 billion, the company has a total of 205,461K Shares Outstanding. Currently, annual sales are 7,394 M while annual income is 1,024 M. The company’s previous quarter sales were 1,940 M while its latest quarter income was 419,000 K.
